|
SFDA issues the No.79 announcement of drug administrative protection
|
|
The State Food and Drug Administration (SFDA) issued the No.79 Drug Administrative Protection Announcement on December 5, 2005, declaring the ending of drug administrative protection for Astra's Naropin (ropivacaine hydrochloride monohydrate).
| |
|
|
